VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Inpatient or outpatient age 8-19 years inclusive;  │ Inpatient or outpatient age 8-19 years inclusive;  │     100 │
│ participants must live with a parent, guardian, or │ participants must live with a parent, guardian, or │         │
│ caregiver                                          │ caregiver                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Fluent in English                                  │ Fluent in English                                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosed or told by a clinician that they have    │ Diagnosed or told by a clinician that they have    │     100 │
│ any of the following bipolar spectrum disorders    │ any of the following bipolar spectrum disorders    │         │
│ (BSD): bipolar I, bipolar II, unspecified bipolar  │ (BSD): bipolar I, bipolar II, unspecified bipolar  │         │
│ and related disorders, Disruptive Mood             │ and related disorders, Disruptive Mood             │         │
│ Dysregulation Disorder (DMDD), cyclothymic         │ Dysregulation Disorder (DMDD), cyclothymic         │         │
│ disorder, other specified bipolar and related      │ disorder, other specified bipolar and related      │         │
│ disorders, as well as mood disorder not otherwise  │ disorders, as well as mood disorder not otherwise  │         │
│ specified (if diagnosed in the past as per DSM-IV) │ specified (if diagnosed in the past as per DSM-IV) │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Received a new or ongoing prescription for at      │ Received a new or ongoing prescription for at      │     100 │
│ least one SGA (i.e., olanzapine, clozapine,        │ least one SGA (i.e., olanzapine, clozapine,        │         │
│ risperidone, quetiapine, aripiprazole,             │ risperidone, quetiapine, aripiprazole,             │         │
│ ziprasidone, iloperidone, lurasidone,              │ ziprasidone, iloperidone, lurasidone,              │         │
│ paliperidone, brexpiprazole or cariprazine) that   │ paliperidone, brexpiprazole or cariprazine) that   │         │
│ is not prescribed as a PRN medication              │ is not prescribed as a PRN medication              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients will be excluded if they have had         │ Patients will be excluded if they have had         │     100 │
│ exposure to a total daily dose of MET 1000 mg bid  │ exposure to a total daily dose of MET 1000 mg bid  │         │
│ for at least 2 weeks in the past 3 months          │ for at least 2 weeks in the past 3 months          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients will be excluded if they could not        │ Patients will be excluded if they could not        │     100 │
│ tolerate MET during the recommended titration      │ tolerate MET during the recommended titration      │         │
│ schedule outlined in the protocol                  │ schedule outlined in the protocol                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant or breast feeding                         │ Pregnant or breast feeding                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Children and caregivers who are unable to complete │ Children and caregivers who are unable to complete │     100 │
│ assessments for any reason                         │ assessments for any reason                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body mass index \>85%ile for age and sex by        │ Body mass index >85%ile for age and sex by         │      99 │
│ standard growth charts                             │ standard growth charts                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Major neurological or medical illnesses that       │ Major neurological or medical illnesses that       │      99 │
│ affect weight gain (e.g., unstable thyroid         │ affect weight gain (e.g., unstable thyroid         │         │
│ disease) or require a systemic medication that     │ disease) or require a systemic medication that     │         │
│ might impact weight or glucose regulation (e.g.,   │ might impact weight or glucose regulation (e.g.,   │         │
│ diabetes mellitus \[insulin\], chronic renal       │ diabetes mellitus [insulin], chronic renal failure │         │
│ failure \[steroids\])                              │ [steroids])                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Fasting glucose ≥ 126 mg/dL on 2 occasions during  │ Fasting glucose = 126 mg/dL on 2 occasions during  │      99 │
│ screening indicating need for prompt treatment     │ screening indicating need for prompt treatment     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ If lab results are available in the last 6 months, │ If lab results are available in the last 6 months, │      99 │
│ then a serum creatinine ≥1.3 mg/dL on 2 occasions  │ then a serum creatinine =1.3 mg/dL on 2 occasions  │         │
│ during screening and/or follow-up, indicating      │ during screening and/or follow-up, indicating      │         │
│ potential impairment of renal functioning          │ potential impairment of renal functioning          │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 8 Years  │ Fluent in English                                  │      33 │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 17 Years │ Children and caregivers who are unable to complete │      33 │
│                                   │ assessments for any reason                         │         │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 98
Average Levenshtein Ratio of individual lines: 90.14285714285714
OverAll Ratio: 94.07142857142857
